Troy Ignelzi

Troy Ignelzi

Chief Financial OfficeratRapport Therapeutics· In proxies 2023–2025

Pay in FY2025+2% from the year before · Rapport Therapeutics stock +71.0% the same year

Troy Ignelzi was paid $2.5M in FY2025 (Dec), up 2%. Rapport Therapeutics stock rose 71.0% that year.

Pay$100 in the stock at the end of FY24 → $171
Pay is from the Summary Compensation Table of each Rapport Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Rapport TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +8%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?